Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amplatzer™Trevisio™Delivery System Post-Approval Study

NCT04433520 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT04433520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04433520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amplatzer™Trevisio™Delivery System Post-Approval Study
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
September 14, 2020
Completion date
January 4, 2023
Enrollment
254 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

asd - atrial septal defect, pfo - patent foramen ovale, pivsd - post infarct muscular ventricular septal defect, vsd - muscular ventricular septal defect